Home » Stocks » PBH

Prestige Consumer Healthcare Inc. (PBH)

Stock Price: $48.50 USD -0.10 (-0.21%)
Updated May 14, 2021 4:00 PM EDT - Market closed
Market Cap 2.42B
Revenue (ttm) 943.37M
Net Income (ttm) 164.68M
Shares Out 49.91M
EPS (ttm) 3.25
PE Ratio 14.92
Forward PE 14.39
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $48.50
Previous Close $48.60
Change ($) -0.10
Change (%) -0.21%
Day's Open 48.95
Day's Range 47.81 - 48.95
Day's Volume 218,696
52-Week Range 32.19 - 48.95

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Prestige Consumer's (PBH) fourth-quarter fiscal 2021 results reflect lower earnings and sales year over year due to pandemic-led disruptions in certain brands and tough comparisons with the year-ago per...

1 week ago - Zacks Investment Research

Prestige Brands (PBH) delivered earnings and revenue surprises of 0.00% and 3.25%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

TARRYTOWN, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2021.

1 week ago - GlobeNewsWire

Lower consumption patterns across certain categories and tough year-over-year comparisons might have hurt Prestige Consumer's (PBH) fourth-quarter fiscal 2021 performance.

1 week ago - Zacks Investment Research

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 weeks ago - Zacks Investment Research

Prestige Consumer Healthcare (PBH) has been benefiting from a strong e-commerce performance as well as efficient saving efforts.

1 month ago - Zacks Investment Research

The rise in consumer confidence in March proves that people are showing faith in the economy, making this an ideal time to invest in consumer discretionary stocks PBH, VSTO, SPB, SWBI, MBUU.

Other stocks mentioned: MBUU, SPB, SWBI, VSTO
1 month ago - Zacks Investment Research

The rise in consumer confidence in March proves that people are showing faith in the economy, making this an ideal time to invest in consumer discretionary stocks PBH, CENT, SPB, MCFT, MBUU.

Other stocks mentioned: CENT, MBUU, MCFT, SPB
1 month ago - Zacks Investment Research

In anticipation of the Fed's big announcement on interest rates and inflation, Q.ai's Artificial Intelligence has brought you today's top buys.

Other stocks mentioned: MWA, PAHC, PG, STRA
1 month ago - Forbes

Prestige Consumer (PBH) has been gaining on strength in the e-commerce business and cost-containment efforts. The company recently raised its guidance for fiscal 2021.

2 months ago - Zacks Investment Research

The rise in consumer confidence in February proves that people are showing faith in the economy, which makes it an ideal time to invest in consumer discretionary stocks like Central Garden Pet Company(C...

Other stocks mentioned: CENT, DKS, HIBB
2 months ago - Zacks Investment Research

Prestige Consumer Healthcare (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

2 months ago - Zacks Investment Research

TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands...

3 months ago - GlobeNewsWire

TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands...

3 months ago - GlobeNewsWire

Prestige Consumer's (PBH) third-quarter fiscal 2021 results reflect stable consumption for most brands and solid e-commerce growth. However, some brands witness lower consumption amid the pandemic.

3 months ago - Zacks Investment Research

Prestige Brands (PBH) delivered earnings and revenue surprises of 5.19% and 2.90%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

TARRYTOWN, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2020.

3 months ago - GlobeNewsWire

Prestige Consumer's (PBH) third-quarter fiscal 2021 performance is likely to reflect soft consumption in certain categories as well as higher advertising and marketing costs.

3 months ago - Zacks Investment Research

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

NEW YORK, Jan. 25, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Staar Surgical Co. (NASD: STAA) will replace Prestige Consumer H...

3 months ago - PRNewsWire

TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third quarter earnings release on Thursday, February 4,...

4 months ago - GlobeNewsWire

Markets sharply reversed during yesterday's trading session. However, the indices ended the day largely mixed.

Other stocks mentioned: AGX, GEF, MMC, PFE
4 months ago - Forbes

Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

Growth-focused investors may want to consider the following small-cap stocks as they represent companies whose trailing 12-month pro forma earnings per share improved significantly on a year-over-year b...

Other stocks mentioned: AMPH, GLDD
6 months ago - GuruFocus

Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q2 2021 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Prestige Consumer's (PBH) second-quarter fiscal 2021 results reflect stable consumption for most brands and robust e-commerce growth. However, some brands see lower consumption amid the pandemic.

6 months ago - Zacks Investment Research

Prestige Brands (PBH) delivered earnings and revenue surprises of 8.33% and 4.42%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

TARRYTOWN, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2020.

6 months ago - GlobeNewsWire

Prestige Consumer's (PBH) second-quarter fiscal 2021 performance is likely to reflect soft consumption in certain categories. Nevertheless, robust cost curtailment efforts bode well.

6 months ago - Zacks Investment Research

TARRYTOWN, N.Y., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 second quarter earnings release on Thursday, November 5...

7 months ago - GlobeNewsWire

The rise in consumer spending comes despite a decline in personal income.

Other stocks mentioned: GO, LCUT, OLLI, SPB
7 months ago - Zacks Investment Research

Prestige Consumer Healthcare (PBH) has been gaining from its focus on healthcare. Apart from this, the company's e-commerce investments and cost-management efforts look impressive.

7 months ago - Zacks Investment Research

Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?

8 months ago - Zacks Investment Research

With no signs of a vaccine yet, fears continue to haunt in spite of strict safety guidelines like social distancing and isolation, and a more cautious approach by people in general.

Other stocks mentioned: GO, OLLI, REYN, SPB
9 months ago - Zacks Investment Research

Prestige Brands Holdings (PBH) CEO Ron Lombardi on Q1 2021 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Prestige Consumer's (PBH) Q1 results gain from solid e-commerce performance and strong free cash flow amid the ongoing pandemic.

9 months ago - Zacks Investment Research

Prestige Brands (PBH) delivered earnings and revenue surprises of 22.86% and 3.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

TARRYTOWN, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2020.

9 months ago - GlobeNewsWire

Impacts of reversal in coronavirus-induced stockpiling trends are like to get reflected in Prestige Consumer's (PBH) first-quarter fiscal 2021 performance.

9 months ago - Zacks Investment Research

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

Major tech giants Amazon and Microsoft will be declaring their quarterly results later this week, and while estimates are reduced, expectations in the market are climbing. Our deep learning algorithms h...

Other stocks mentioned: CHTR, ERIE, ICE, VZ, VZA
9 months ago - Forbes

TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first quarter earnings release on Thursday, August 6,...

10 months ago - GlobeNewsWire

Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock?

11 months ago - Zacks Investment Research

PBH vs. UNICY: Which Stock Is the Better Value Option?

Other stocks mentioned: UNICY
11 months ago - Zacks Investment Research

Prestige Consumer Healthcare Inc. (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

11 months ago - Zacks Investment Research

Prestige Brands Holdings (PBH) CEO Ron Lombardi on Q4 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Prestige Consumer's (PBH) fourth-quarter fiscal 2020 results reflect solid consumption trends at core brands in the domestic regions and strong international unit performance.

1 year ago - Zacks Investment Research

Prestige Brands (PBH) delivered earnings and revenue surprises of 10.81% and 4.48%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

As of late, it has definitely been a great time to be an investor in Prestige Consumer Healthcare.

1 year ago - Zacks Investment Research

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG ora... [Read more...]

Industry
Medical Distribution
IPO Date
Feb 10, 2005
Stock Exchange
NYSE
Ticker Symbol
PBH
Full Company Profile

Financial Performance

In 2020, PBH's revenue was $943.37 million, a decrease of -2.04% compared to the previous year's $963.01 million. Earnings were $164.68 million, an increase of 15.74%.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for PBH stock is "Buy." The 12-month stock price forecast is 51.50, which is an increase of 6.19% from the latest price.

Price Target
$51.50
(6.19% upside)
Analyst Consensus: Buy